Rapid diagnostic tests (RDTs) for malaria parasites are essential for quick and accurate diagnosis, especially in resource-limited settings. Traditional methods like stained blood films, while effective, have limitations in sensitivity and specificity, particularly for detecting low parasitemia. RDTs, such as immunochromatographic tests, offer a faster alternative, detecting specific antigens like HRP-2, pLDH, and aldolase. These tests are designed to detect 100 parasites/μl from all Plasmodium species and provide semiquantitative results for monitoring treatment efficacy. However, challenges remain, including the persistence of HRP-2 after treatment, which can lead to false positives, and the need for accurate interpretation of results. While RDTs are valuable, they are not a complete replacement for microscopy, especially in diagnosing non-falciparum malaria. PCR-based methods offer high sensitivity but are not rapid enough for routine use. The development of more accurate and cost-effective RDTs is crucial for improving malaria diagnosis and treatment outcomes globally.Rapid diagnostic tests (RDTs) for malaria parasites are essential for quick and accurate diagnosis, especially in resource-limited settings. Traditional methods like stained blood films, while effective, have limitations in sensitivity and specificity, particularly for detecting low parasitemia. RDTs, such as immunochromatographic tests, offer a faster alternative, detecting specific antigens like HRP-2, pLDH, and aldolase. These tests are designed to detect 100 parasites/μl from all Plasmodium species and provide semiquantitative results for monitoring treatment efficacy. However, challenges remain, including the persistence of HRP-2 after treatment, which can lead to false positives, and the need for accurate interpretation of results. While RDTs are valuable, they are not a complete replacement for microscopy, especially in diagnosing non-falciparum malaria. PCR-based methods offer high sensitivity but are not rapid enough for routine use. The development of more accurate and cost-effective RDTs is crucial for improving malaria diagnosis and treatment outcomes globally.